soul trial oral semaglutide cardiovascular outcomes results 2024 2025 Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π Researchers to present CV findings
Description
But reducing body weight is only one piece of a much larger metabolic puzzle
GLP-1s also interact with receptors in your brain and brainstem that regulate food intake and energy use
Biomater Adv
Fat-soluble vitamins (A, D, E, and K) should be taken with meals containing some dietary fat to optimize absorption
Contents: Semaglutide (Peptide Compound)
